The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials-Reference-Cited by-同舟云学术

The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials

Published:2016-04-12 Issue:4 Volume:13 Page:e1001992
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Rados Dimitris Varvaki,Pinto Lana Catani,Remonti Luciana Reck,Leitão Cristiane Bauermann,Gross Jorge Luiz

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference93 articles.

1. Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis;JA Hirst;Diabetologia,2013

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

3. Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin;S Klarenbach;CMAJ,2011

4. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results;CL Meinert;Diabetes,1970

5. Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? No, it’s time to move on!;S Genuth;Diabetes Care,2015

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiles of sulfonylurea use in Diabetes Mellitus type 2: an analysis of clinical practice over the last 10 years;Diabetes Research and Clinical Practice;2024-08

2. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10

3. Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk;Nature Cardiovascular Research;2024-04-03

4. Therapie des Typ-2-Diabetes;Die Diabetologie;2024-01-30

5. Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial;BMJ Medicine;2023-08